BioPharma Credit (LON:BPCR – Get Free Report) shares crossed above its 50 day moving average during trading on Thursday. The stock has a 50 day moving average of GBX 0.97 and traded as high as GBX 0.98. BioPharma Credit shares last traded at GBX 0.98, with a volume of 2,361,853 shares trading hands.
BioPharma Credit Price Performance
The stock has a market capitalization of £11.09 million, a price-to-earnings ratio of 0.10 and a beta of 0.23. The stock’s 50 day simple moving average is GBX 0.97 and its 200-day simple moving average is GBX 0.95.
Insider Buying and Selling at BioPharma Credit
In other BioPharma Credit news, insider Graeme Proudfoot purchased 70,000 shares of the business’s stock in a transaction dated Tuesday, September 29th. The shares were acquired at an average price of GBX 99 per share, for a total transaction of £69,300. Corporate insiders own 0.09% of the company’s stock.
About BioPharma Credit
BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in London, the United Kingdom.
Further Reading
- Five stocks we like better than BioPharma Credit
- Dutch Bros Gave Wall Street What It Wanted, So Why Did the Stock Crater?
- Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?
- Sandisk Shares Are Oversold: Bargain or Value Trap?
- IonQ’s Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?
Receive News & Ratings for BioPharma Credit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioPharma Credit and related companies with MarketBeat.com's FREE daily email newsletter.
